SCHEMBL7450383

SCHEMBL7450383

CCCN(CCC)[C@@H]1CCc2c(ccc3[nH]cc(C=O)c23)[C@@H]1C

nearest known ligand 0.60

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HTR1B P28222 15/20 0.60
HTR1D P28221 15/20 0.60
HTR1A P08908 3/20 0.60
DRD4 P21917 2/20 0.50
DRD3 P35462 2/20 0.50
MEN1 O00255 1/20 0.50
CYP1A2 P05177 1/20 0.50
DRD2 P14416 1/20 0.50
TSHR P16473 1/20 0.50
HTR5A P47898 1/20 0.50
KMT2A Q03164 1/20 0.50
HTR2A P28223 1/20 0.48
HTR2C P28335 1/20 0.48
HTR2B P41595 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7450390 1.00 HTR1B (0.60) HTR1BHTR1DHTR1ADRD4DRD3
SCHEMBL7450379 1.00 HTR1B (0.60) HTR1BHTR1DHTR1ADRD4DRD3
SCHEMBL7448912 0.77 HTR1D (0.84) HTR1BHTR1DHTR1A
SCHEMBL7439194 0.77 HTR1D (0.84) HTR1BHTR1DHTR1A
SCHEMBL8312369 0.75 HTR1D (1.00) HTR1BHTR1DHTR1A
SCHEMBL7435314 0.75 DRD2 (0.56) HTR1BHTR1DHTR1ADRD4DRD3
SCHEMBL7439927 0.75 DRD2 (0.56) HTR1BHTR1DHTR1ADRD4DRD3
SCHEMBL7439930 0.75 DRD2 (0.56) HTR1BHTR1DHTR1ADRD4DRD3
SCHEMBL8312983 0.71 HTR1B (1.00) HTR1BHTR1DHTR1A
SCHEMBL8316699 0.71 HTR1D (1.00) HTR1BHTR1DHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0690843-B1 Formyl- or cyano- substituted indole derivatives having dopaminergic activity UPJOHN CO (US) 2000-08-30 EP disclosed
US-5639778-A TREATING CENTRAL NERVOUS SYSTEM DISORDERS PHARMACIA & UPJOHN COMPANY (US) 1997-06-17 US disclosed
WO-1994021608-A1 INDOLETETRALINS HAVING DOPAMINERGIC ACTIVITY THE UPJOHN COMPANY (US) 1994-09-29 WO disclosed